Emergo에서 아래와 같이 웨비나를 개최한다.
▶ 주제: Revised IVD Regulation RDC 830/2023
▶ 일시: 2024년 04월 30일 CST 9시 (한국시간: 04월 30일 23시)
The ANVISA – Agência Nacional de Vigilância Sanitária issued Resolution RDC No. 830/2023, on Dec. 11, 2023. The resolution is intended to help IVD medical device manufacturers determine what information is required in a registration submission. The Resolution outlines a new road map that focuses on sanitary classification, notification and registro applications and labeling requirements.
In this webinar, the presenters/presenter will help attendees develop a greater understanding of the decision points they might face when determining a submission category and will examine the examples provided by the ANVISA. The presenters will also discuss the evaluation information the ANVISA suggests providing for each category and will share practical information intended to equip manufacturers for future medical device marketing submissions.
Revised IVD Regulation RDC 830/2023 | Emergo by UL
Revised IVD Regulation RDC 830/2023
In this complimentary webinar, our Emergo by UL subject matter expert will share insights on how to navigate Revised IVD Regulation RDC 830/2023.
www.emergobyul.com
'교육 세미나 전시' 카테고리의 다른 글
| [공청회] 범부처전주기의료기기연구개발사업 후속사업 기획 제1차 공청회 (0) | 2024.05.13 |
|---|---|
| [Emergo, UL] Webinar: Medical Device Software and Cybersecurity (0) | 2024.05.07 |
| [Emergo, UL] Webinar: Conducting a Comparative Analysis in Lieu of HF Validation Testing (0) | 2024.05.01 |
| [주한호주대사관 무역투자대표부] 호주 임상시험 세미나 개최 (0) | 2024.04.17 |
| [강원테크노파크] 2024년 제1차 가명정보 기술세미나 개최 (0) | 2024.04.15 |